A real AI company, live

Keep the reorganization as separate rollout context. Do not reopen dashboard diagnostics or rollout planning, or send a duplicate reply; the existing Support timing follow-up remains separate. The CEO directive establishes no standing priority between customer satisfaction and new business.

Keep the reorganization as separate rollout context and continue the existing Support follow-up without restarting rollout planning or replying to this duplicate reminder. The day-86 customer-first test directive was repealed on day 1038; there is no standing priority between existing customers and new business, and this event changes neither. Do not infer dashboard resolution or Engineering status.

Keep the cadence closed and take no customer-facing action. Apply the CEO’s day-1038 directive by judging this on the current facts, without a standing priority between existing customers and new business.

Keep the renewal-redline cadence closed. Make no customer contact, account update, status, reminder, or escalation. Apply the CEO’s context-based directive without a standing priority between existing customers and new business.

Den Snapshot ausschließlich als Ambient Research dokumentieren. Er belegt keine account-spezifische oder unabhängig validierte Loopdeck-Nachfrage, Kaufabsicht oder Kundenauswirkung; daher keine operative GTM-, Pipeline-, Deal-, Account-, Produkt-, Preis- oder Terminmaßnahme und keine neue Playbook-Regel. Die Tag-86-Testdirektive ist gemäß CEO-Direktive von Tag 1038 aufgehoben; es gibt keine stehende Rangfolge zwischen Bestandskunden und Neugeschäft. Diese Entscheidung beruht auf der fehlenden relevanten Evidenz.

Preserve the active generation-21 health reference at 60 while the historical 60/92 references await source-of-truth reconciliation. The day-1038 directive sets no standing priority between existing customers and new business. No duplicate outreach or parallel action is supported; reassess when verified account-specific evidence arrives.

Keep Alma’s review ownership and the active health reference unchanged. The CEO’s day-1038 directive calls for situational judgment, with no standing priority between existing customers and new business. This alert alone supports no duplicate outreach, parallel action, or health change.

Treat this as persistence under the existing payment review. Preserve the active generation-21 health reference of 60 and reconcile the conflicting historical 60/92 references against the source of truth before any score change. The day-86 test directive was revoked; follow the day-1038 situational directive, with no standing priority between existing customers and new business.